GlassScriptPhysician profile
Lauren Jones
NPI 1902567662
$1,810.56
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,023 · 2023: $762 · 2024: $25.93.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $788.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $787.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $448.30 | 2022-2024 | Relistor |
| Collegium Pharmaceutical, INC. | $428.81 | 2022-2023 | Xtampza |
| Abbvie INC. | $174.83 | 2022-2023 | |
| Medtronic, INC. | $162.66 | 2022 | |
| Redhill Biopharma INC. | $124.10 | 2022 | |
| Scilex Pharmaceuticals INC. | $119.11 | 2022-2023 | Ztlido |
| Electronic Waveform Lab, INC. | $58.89 | 2022 | |
| Averitas Pharma INC. | $52.83 | 2023 | Qutenza |
| Lilly USA, LLC | $50.41 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $42.69 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $39.97 | 2022 | |
| Spinal Simplicity, LLC | $23.73 | 2023 | Ha Minuteman G3-R |
| Pfizer INC. | $18.64 | 2023 | |
| Sanofi-Aventis U.S. LLC | $17.89 | 2023 | |
| Novo Nordisk INC | $17.02 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Grt US Holding, INC. | $16.07 | 2022 | |
| Stimwave Technologies Incorporated | $14.61 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lauren Jones listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.